ramipril/rosuvastatin calcium

N/A

Report date: 2025/07/22 15:55:30

Base Information

Drug Nameramipril/rosuvastatin calcium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsHMG-CoA reductase inhibitors
TargetsAngiotensin-converting enzymeHMG-CoA reductase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesEgis Pharmaceuticals PLC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeC10BX
Related LinksN/A